Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

NCT06274554 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease
Inflammatory Bowel Diseases

Interventions

DRUG: Fluconazole
DRUG: Placebo
BIOLOGICAL: IL-23 Therapy

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]